TD Vaccine Market by Vaccine Type (Tetanus-Diphtheria Vaccine, Tetanus-Diphtheria-Pertussis Vaccine), By Age Group (Paediatric, Adult, Others), By Route of Administration (Intramuscular, Subcutaneous), By End-user (Hospitals, Clinics, Vaccination Centres, Homecare Settings) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Published Date: Feb 2025 | Report ID: MI2059 | 215 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Vaccine Type

  • Tetanus-Diphtheria (TD) Vaccine
  • Tetanus-Diphtheria-Pertussis (Tdap) Vaccine

By Age Group

  • Pediatric
  • Adult
  • Others

By Route of Administration:

  • Intramuscular (IM)
  • Subcutaneous (SC)

By End-user

  • Hospitals
  • Clinics
  • Vaccination Centers
  • Homecare Settings

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Sanofi
  • GSK plc.
  • Merck & Co., Inc.
  • Panacea Biotec
  • Serum Institute of India Pvt. Ltd.
  • Bionet-Asia
  • Meiji Holdings Co., Ltd.
  • Biological E Limited
  •  Incepta Pharmaceuticals Ltd.
  • BB-NCIPD Ltd.
  • Grifols, S.A.
  • Pfizer Inc.
  • EMERGENT
  • AstraZeneca
  • Sinovac
  • Bavarian Nordic
  • Valneva SE.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing